About 1,490,840 results (3,070 milliseconds)

WO2008049231A1 - Tissue targeted antigenic activation of the ...

https://patents.google.com/patent/WO2008049231A1/en
[0033] Figure 4 shows a survival curve for a cumulative series of patients diagnosed with stage 3B or 4 lung cancer, illustrating the effect of treatments for ...

EP2598165A1 - Immunogenic anti-inflammatory compositions ...

https://patents.google.com/patent/EP2598165A1/en
[0071] Figure 4 shows a survival curve for a cumulative series of patients diagnosed with stage 3B or 4 lung cancer, illustrating the effect of treatments for ...

US10316093B2 - Antibodies, compositions, and uses - Google ...

https://patents.google.com/patent/US10316093B2/en
... tumor, heart, lung, spine, and brain. Count rates were background and decay ... metastatic malignant brain tumors: phase II study results. J. Clin ...

RU2722357C2 - Immunogenic anti-inflammatory compositions ...

https://patents.google.com/patent/RU2722357C2/en
Figure 4 shows a survival curve for a cumulative series of patients diagnosed with lung cancer at stages 3B or 4, illustrating the effect of treatment ...

RU2581922C2 - Immunogenic anti-inflammatory compositions ...

https://patents.google.com/patent/RU2581922C2/en
Figure 4 shows a survival curve for a cumulative series of patients diagnosed with lung cancer at stages 3B or 4, illustrating the effect of ...

US10752667B2 - EPHA3 and multi-valent targeting of tumors ...

https://patents.google.com/patent/US10752667B2/en
“Brain cancer” or “brain tumor” may be of any stage ... Oligodendrogliomas, which make up 4% of brain tumors, mostly affect people over 45 years of age.

WO2022208391A1 - 3,4-dihydro-2,7-naphthyridine-1,6(2h,7h ...

https://patents.google.com/patent/WO2022208391A1/en
In one embodiment, the MEK-associated metastatic brain cancer is metastatic non-small cell lung cancer. ... tumors that start in the brain or spine and are known ...

US9868788B2 - Antibodies against human and canine IL-13RA2 ...

https://patents.google.com/patent/US9868788B2/en
“Brain cancer” or “brain tumor” may be any stage ... CN112805036A 2021-05-14 Treatment of metastatic brain tumors by administration of antibody-drug conjugates.

WO2009036388A2 - Gene signature for the prediction of radiation ...

https://patents.google.com/patent/WO2009036388A2/en
Pathological Tumor Stage. TONO 4 (33.3) ... 2015 Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data.

NL2024544B1 - Compositions And Methods For Cancer Therapy ...

https://patents.google.com/patent/NL2024544B1/en
Patients diagnosed at an early stage (Dukes' A and B) with no evidence of metastatic disease at the time of surgery have a significantly better prognosis having ...

US20170112894A1 - Peptides and peptidomimetics in combination ...

https://patents.google.com/patent/US20170112894A1/en
... cancer, hepatomas, venal carcinomas, lung and brain tumors/cancers. A “liquid ... metastatic (stage IV) non-squamous NSCLC. [0306]. Secondary: [0307]. To ...

US20190175560A1 - Mebendazole cancer therapies and methods ...

https://patents.google.com/patent/US20190175560A1/en
Stage 4, or metastatic cancers, are typically cancers that have spread from ... lung cancer ib-iii stage using personalized perioperative chemotherapy.

WO2019126739A1 - Pyrvinium pamoate anti-cancer therapies ...

https://patents.google.com/patent/WO2019126739A1/en
... lung cancer, a brain cancer, a pancreatic cancer or a renal cancer. In ... Stage 4, or metastatic cancers, are typically cancers that have spread from ...

US20080248033A1 - VEGF-specific antagonists for adjuvant and ...

https://patents.google.com/patent/US20080248033A1/en
... stage major cancer indications such as lung, breast and colorectal cancers. ... metastatic cancer from progressing to a stage III or stage IV cancer. 5. The ...

US20160160295A1 - Non-coding rnas and uses thereof - Google ...

https://patents.google.com/patent/US20160160295A1/en
Treatment options depend on the stage of the cancer. Men with a 10-year life expectancy or less who have a low Gleason number and whose tumor has not spread ...

WO2019109074A1 - Mebendazole cancer therapies and methods of ...

https://patents.google.com/patent/WO2019109074A1/en
Jun 6, 2019 ... ... cancer or stage 3 (spread to nearby tissues and lymph nodes) cancer. In some embodiments, the cancer is a stage 4 (advanced or metastatic) ...

WO2009110944A1 - Modified toxins - Google Patents

https://patents.google.com/patent/WO2009110944A1/en
... carcinoma, metastatic prostate cancer, metastatic ovarian cancer and metastatic lung cancer. ... prognosis and potential treatment of lung cancer. Non ...

Brain Mets | Palliative | Oligo | Immuno

https://docs.google.com/document/d/1CfbqB4YnaPB8U3r2LykLv2v3bRLJyYQV0tvX4Js2Mog/edit
There is a survival benefit with early palliative care! 151 newly diagnosed metastatic NSCLC pts. Better QoL, less depression, longer MS. Aggressive end of life ...

US9587239B2 - Methods of identifying and treating glioblastoma ...

https://patents.google.com/patent/US9587239B2/en
4 depicts paraffin sections of tumor free non-neoplastic brain, glioblastoma core, and invasive rim. FIG. 5 depicts a decrease in NHERF-1 protein expression in ...

WO2009051848A1 - Pharmaceutical compositions for modulating a ...

https://patents.google.com/patent/WO2009051848A1/en
... spread of other cancers, such as lung or breast to the brain. [00073 ] Brain ... metastasize to different locations in the brain and spine. The peak of ...